Tympanoplsty with or without mastoidectmy is highly effective treatment of chronic otitis media in padiatric age

Hukam Singh1, Monika Patel2, Udita Arora3

  • 1Department of Otorhinolaryngology and Head & Neck Surgery, Government Institute of Medical Sciences, Greater Noida, Rama Medical College and Research Centre, District- Gautam Buddha Nagar, NH-24, District-Hapur, Rama City, U.P, India.

Insights

This study found that intact canal wall mastoidectomy with type first tympanoplasty offers high success rates for pediatric Chronic Suppurative Otitis Media (CSOM) patients. Both surgical approaches demonstrated significant improvements in graft healing and conductive hearing loss.

Area of Science:

  • Otolaryngology
  • Pediatric Surgery
  • Audiology

Background:

  • Chronic Suppurative Otitis Media (CSOM) is a common condition in pediatric patients, often leading to hearing loss.
  • Tympanoplasty and mastoidectomy are surgical interventions used to treat CSOM and its complications.
  • Assessing the prognostic value of surgical variables is crucial for optimizing outcomes in pediatric CSOM management.

Purpose of the Study:

  • To evaluate the prognostic significance of various factors on surgical outcomes in pediatric patients undergoing tympanoplasty alone or combined with intact canal wall mastoidectomy for CSOM.
  • To compare the success rates of Type I tympanoplasty versus Type I tympanoplasty combined with intact canal wall mastoidectomy in managing CSOM in children.

Main Methods:

  • A retrospective study involving 140 pediatric patients (ages 6-18) with CSOM and impaired hearing.
  • Patients were divided into two groups: Type I tympanoplasty (Group-1) and intact canal wall mastoidectomy with Type I tympanoplasty (Group-2).
  • Surgical outcomes were assessed based on tympanic membrane healing, graft healing, and improvement in conductive hearing loss, with follow-up for 6 months to 5 years.

Main Results:

  • The study included 140 pediatric patients, with a higher prevalence in females (59%) and the right ear (76%).
  • Tympanic membrane healing rates were high across all groups, with 100% in younger age groups (6-10 years).
  • Graft healing success was 96.57% for intact canal wall mastoidectomy with Type I tympanoplasty and 89.77% for Type I tympanoplasty alone. Conductive hearing loss improved by 91.30% and 88.57% respectively.

Conclusions:

  • Intact canal wall mastoidectomy combined with Type I tympanoplasty demonstrated a high success rate in graft healing and conductive hearing improvement in pediatric CSOM patients.
  • Both surgical techniques showed favorable outcomes, indicating their efficacy in managing CSOM in this age group.
  • Further analysis of predictive variables is warranted to refine prognostic assessments for these procedures.
Abstract